Research Article
Astragalus Membranaceus Treatment Protects Raw264.7 Cells from Influenza Virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway
Figure 6
Effects of AMI (92 mg/ml) on the mechanism of Raw264.7 cells infected with influenza virus.